Benefits
A prescribed medicine’s diluent; sterile water is not phosphate-buffered saline or bacteriostatic water.
Named U.S. presentation only; selected label sections.
Peptide library
Sterile Water for Injection
Your guide to this compound.
Mechanism illustrationEnlarge
Evidence in perspective
The named U.S. product label is the appropriate source for its approved use, contraindications and handling. A medicine-like elimination half-life is not applicable to sterile water used as a diluent. It is not phosphate-buffered saline, and it does not determine the persistence of a dissolved medicine. A label extraction is not an independent appraisal of every supporting trial or approval of other products with the same ingredient.
About this assessment
Named U.S. product label sections assessed.
Product-specific editorial extraction. Complete clinical review and clinician sign-off remain pending; other jurisdictions are not inferred.
Editorial assessment · 2026-09-07
Who was studied
The population specified by this product label; other indications and jurisdictions remain outside this check.
What the sources found
A prescribed medicine’s diluent; sterile water is not phosphate-buffered saline or bacteriostatic water.
Regulatory scope
U.S. label record for NDA018801. This does not confer authorization on other products using the ingredient name.
What remains unknown
Named-product label sections were expanded for pharmacokinetics, contraindications and selected handling or interaction details on September 7, 2026. This is not a complete trial-program appraisal or clinician sign-off. Other formulations, patient-specific decisions and other jurisdictions require separate assessment.
How it works
Henry Schein/Hospira Sterile Water for Injection, single-dose vial
Consult the product label for pharmacology. A mechanism does not extend its approved indications.
Approved product exists
Approval applies to a particular product and indication. It does not extend to every use, route, compounded preparation or research vial sold under the same compound name. Check the current prescribing information.
Reported adverse effects
- Undiluted intravenous water can cause hemolysis; compatibility and tonicity depend on the medicine being prepared.
Named U.S. presentation only; selected label sections.
Contraindications
- Sterile Water for Injection must be made approximately isotonic before use. It is not intended for direct IV administration alone.
Approved product exists
Approval applies to a particular product and indication. It does not extend to every use, route, compounded preparation or research vial sold under the same compound name. Check the current prescribing information.
Sources used for this snapshot
Claim-by-claim evidence
Adverseeffects
Undiluted intravenous water can cause hemolysis; compatibility and tonicity depend on the medicine being prepared.
Named U.S. presentation only; selected label sections.
Storage
This sterile-water presentation: 20–25°C; single-dose use. A diluent’s storage cannot establish a mixed medicine’s stability.
Named U.S. presentation only; selected label sections.
Pharmacokinetics
A medicine-like elimination half-life is not applicable to sterile water used as a diluent. It is not phosphate-buffered saline, and it does not determine the persistence of a dissolved medicine.
Named U.S. product only; label revision 20251107. Educational extraction, not complete clinical review.
Contraindications
Sterile Water for Injection must be made approximately isotonic before use. It is not intended for direct IV administration alone.
Named U.S. product only; label revision 20251107. Educational extraction, not complete clinical review.
References
Henry Schein/Hospira Sterile Water for Injection, single-dose vial. U.S. structured product label, effective 20251107. Selected sections only.
Catalog review date: Sep 7, 2026. This date alone does not establish independent clinical review.